Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

FRANCONIA PEDIATRICS ASSOCIATES

NPI: 1336542042 · ALEXANDRIA, VA 22310 · Primary Care Clinic/Center · NPI assigned 10/08/2014

$3.03M
Total Medicaid Paid
95,978
Total Claims
87,922
Beneficiaries
66
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialNAVALKAR, SUSHANT (OWNER)
NPI Enumeration Date10/08/2014

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 11,410 $358K
2019 13,266 $376K
2020 12,172 $378K
2021 13,146 $416K
2022 15,429 $510K
2023 16,262 $530K
2024 14,293 $458K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 20,724 17,588 $1.24M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 4,163 4,069 $317K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 3,540 3,455 $271K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 2,859 2,777 $236K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 2,403 2,183 $171K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1,700 1,516 $138K
92551 8,028 7,839 $77K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2,067 1,966 $69K
96110 Developmental screening, with scoring and documentation, per standardized instrument 6,708 5,845 $61K
90651 1,363 1,326 $53K
90670 1,691 1,635 $40K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2,746 2,578 $35K
90686 2,521 2,430 $29K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,954 927 $26K
81002 7,980 7,513 $22K
90680 1,283 1,224 $21K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 575 536 $20K
99173 8,120 7,928 $19K
90619 400 391 $16K
96127 3,281 3,195 $15K
90734 489 482 $15K
90633 1,159 1,133 $15K
90710 598 592 $13K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 821 784 $13K
90698 777 742 $13K
90677 260 224 $12K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 122 120 $10K
0072A 171 170 $7K
0071A 168 167 $7K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 500 429 $5K
90647 353 344 $4K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 131 128 $4K
90715 236 229 $4K
90460 Immunization administration through 18 years of age via any route, first or only component 465 342 $4K
90744 259 247 $3K
90672 117 99 $2K
90621 51 47 $2K
87428 77 75 $2K
90656 148 148 $2K
99174 439 426 $2K
90700 161 154 $2K
90620 73 69 $2K
A7005 Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable 144 128 $2K
0001A 38 37 $1K
90696 69 66 $1K
A7006 Administration set, with small volume filtered pneumatic nebulizer 195 171 $944.26
0002A 21 21 $840.00
99000 256 249 $706.56
96161 542 424 $584.73
94760 406 340 $533.69
87807 36 31 $408.08
99050 32 32 $374.13
99188 13 13 $270.27
90723 15 15 $244.04
97802 138 138 $183.72
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 45 37 $161.10
A7004 Small volume nonfiltered pneumatic nebulizer, disposable 86 81 $117.89
A7015 Aerosol mask, used with dme nebulizer 111 99 $110.57
99051 65 62 $88.50
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 369 314 $14.46
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 97 85 $12.45
91307 393 332 $2.56
91300 70 50 $0.43
G8510 Screening for depression is documented as negative, a follow-up plan is not required 1,095 1,066 $0.00
99072 47 46 $0.00
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 14 13 $0.00